34177264|t|MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3beta/Nrf2/ARE Signaling.
34177264|a|PURPOSE: MicroRNAs (miRNAs) are emerging as essential regulators in the development of cerebral ischemia/reperfusion (I/R) injury. This study aimed to explore the regulation of miR-9-3p on FGF19-GSK-3beta/Nrf2/ARE signaling in cerebral I/R injury. MATERIALS AND METHODS: A mouse model with I/R injury was constructed by middle cerebral artery occlusion (MCAO) and an HT22 cell model was established by oxygen-glucose deprivation/reperfusion (OGD/R). The expression of miR-9-3p was detected by RT-qPCR. Protein expression of fibroblast growth factor 19 (FGF19), cleaved caspase-3, and GSK-3beta signaling-related proteins (p-GSK-3beta and Nrf2) were detected by Western blot. Cell viability was assessed by MTT assay. Oxidative stress was detected by commercial kits. The target of miR-9-3p was predicted by TargetScan and confirmed by luciferase reporter assay. The effects of miR-9-3p on GSK-3beta/Nrf2/ARE signaling were assessed by rescue experiments. RESULTS: MiR-9-3p was significantly upregulated in brain tissues of MCAO/R-treated mice and OGD/R-treated HT22 cells. Downregulation of miR-9-3p attenuated infarct volume and neurological outcomes of MCAO/R-treated mice in vivo and OGD/R-induced cell injury and oxidative stress in vitro, while overexpression of miR-9-3p showed the opposite effects. MiR-9-3p directly bound to the 3'-untranslated region of FGF19 and negatively regulated its expression. Inhibition of miR-9-3p enhanced GSK-3beta/Nrf2/ARE signaling-mediated antioxidant response, while this effect was partially eliminated by FGF19 or Nrf2 silencing. CONCLUSION: Our study suggests that inhibition of miR-9-3p protects against cerebral I/R injury through activating GSK-3beta/Nrf2/ARE signaling-mediated antioxidant responses by targeting FGF19, providing a potential therapeutic target for ischemic stroke.
34177264	0	13	MicroRNA-9-3p	Gene	723968
34177264	25	42	Cerebral Ischemia	Disease	MESH:D002545
34177264	43	61	Reperfusion Injury	Disease	MESH:D015427
34177264	75	102	Fibroblast Growth Factor 19	Gene	14170
34177264	104	109	FGF19	Gene	14170
34177264	125	134	GSK-3beta	Gene	56637
34177264	135	139	Nrf2	Gene	18024
34177264	242	284	cerebral ischemia/reperfusion (I/R) injury	Disease	MESH:D015427
34177264	332	340	miR-9-3p	Gene	723968
34177264	344	349	FGF19	Gene	14170
34177264	350	359	GSK-3beta	Gene	56637
34177264	360	364	Nrf2	Gene	18024
34177264	382	401	cerebral I/R injury	Disease	MESH:D015427
34177264	428	433	mouse	Species	10090
34177264	445	455	I/R injury	Disease	MESH:D015427
34177264	475	507	middle cerebral artery occlusion	Disease	MESH:D020244
34177264	509	513	MCAO	Disease	MESH:D020244
34177264	522	526	HT22	CellLine	CVCL:0321
34177264	557	563	oxygen	Chemical	MESH:D010100
34177264	564	571	glucose	Chemical	MESH:D005947
34177264	597	600	OGD	Disease	MESH:C536050
34177264	623	631	miR-9-3p	Gene	723968
34177264	679	706	fibroblast growth factor 19	Gene	14170
34177264	708	713	FGF19	Gene	14170
34177264	724	733	caspase-3	Gene	12367
34177264	739	748	GSK-3beta	Gene	56637
34177264	779	788	GSK-3beta	Gene	56637
34177264	793	797	Nrf2	Gene	18024
34177264	861	864	MTT	Chemical	MESH:C070243
34177264	936	944	miR-9-3p	Gene	723968
34177264	1032	1040	miR-9-3p	Gene	723968
34177264	1044	1053	GSK-3beta	Gene	56637
34177264	1054	1058	Nrf2	Gene	18024
34177264	1119	1127	MiR-9-3p	Gene	723968
34177264	1178	1182	MCAO	Disease	MESH:D020244
34177264	1193	1197	mice	Species	10090
34177264	1202	1205	OGD	Disease	MESH:C536050
34177264	1216	1220	HT22	CellLine	CVCL:0321
34177264	1246	1254	miR-9-3p	Gene	723968
34177264	1266	1273	infarct	Disease	MESH:D007238
34177264	1310	1314	MCAO	Disease	MESH:D020244
34177264	1325	1329	mice	Species	10090
34177264	1342	1345	OGD	Disease	MESH:C536050
34177264	1423	1431	miR-9-3p	Gene	723968
34177264	1461	1469	MiR-9-3p	Gene	723968
34177264	1518	1523	FGF19	Gene	14170
34177264	1579	1587	miR-9-3p	Gene	723968
34177264	1597	1606	GSK-3beta	Gene	56637
34177264	1607	1611	Nrf2	Gene	18024
34177264	1703	1708	FGF19	Gene	14170
34177264	1712	1716	Nrf2	Gene	18024
34177264	1778	1786	miR-9-3p	Gene	723968
34177264	1804	1823	cerebral I/R injury	Disease	MESH:D015427
34177264	1843	1852	GSK-3beta	Gene	56637
34177264	1853	1857	Nrf2	Gene	18024
34177264	1916	1921	FGF19	Gene	14170
34177264	1968	1983	ischemic stroke	Disease	MESH:D002544
34177264	Positive_Correlation	MESH:D015427	723968
34177264	Association	14170	56637
34177264	Positive_Correlation	MESH:D002545	723968
34177264	Association	14170	723968
34177264	Positive_Correlation	MESH:C536050	723968
34177264	Association	MESH:D015427	18024
34177264	Negative_Correlation	56637	723968
34177264	Association	MESH:D005947	MESH:C536050
34177264	Association	MESH:D015427	14170
34177264	Association	18024	56637
34177264	Negative_Correlation	14170	18024
34177264	Positive_Correlation	MESH:D007238	723968
34177264	Association	MESH:D015427	56637
34177264	Positive_Correlation	MESH:D020244	723968
34177264	Negative_Correlation	18024	723968

